Details of the Drug

General Information of Drug (ID: DMRWA3M)

Drug Name

Lu-177-PSMA-I&T

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Radioligand therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05204927) A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T Versus Hormone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer. U.S.National Institutes of Health.